Breast Cancer
Vector-activated dendritic cell injection and chemotherapy suppresses breast cancer
Published in Health Risk Factor Week, November 14th, 2006
"S.c. injection of the Ad-sig-tumor-associated antigen (TAA)/ecdCD40L vector vaccine has been shown to induce a CD8 immune response against TAA for up to 1 year.The first goal of this article is to test if the injection of autologous dendritic cells infected ex vivo with the Ad-sig-TAA/ecdCD40L can increase the immune response induced against TAA.
"The second goal is to test the effect of adding local chemotherapy in the form of Lt. injection of the AdCDIRESE1A vector-directed chemotherapy on the immune response induced by Lt. injection of adenoviral vector-activated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
More Articles from Health Risk Factor Week
- Aspergillosis Risk Factors
Studies from University of Barcelona, Hematology Department describe new findings in aspergillosis risk factors - Aspergillosis Therapy
Research on aspergillosis therapy published by scientists at University of Michigan, Department of Internal Medicine - Bioterrorism
Studies from University of Chicago add new findings in the area of bioterrorism - Bovine Coronavirus Outbreaks
Bovine coronavirus detected in dysentery outbreak in Cuba - Buruli Ulcer Risk
Buruli ulcer risk higher in Bacillus Calmette-Guerin-vaccinated persons in Benin - Cancer Vaccine
Tumor-associated antigen-specific DNA vaccine induces protective and therapeutic antitumor immunity - More from this issue of Health Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
